These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6681897)

  • 21. The effect of growth hormone treatment on somatomedin levels in growth hormone-deficient children.
    Dean HJ; Kellett JG; Bala RM; Guyda HJ; Bhaumick B; Posner BI; Friesen HG
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1167-73. PubMed ID: 6752166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunoassayable serum somatomedin B in normal subjects and in patients with acromegaly and pituitary dwarfism: effects of human growth hormone therapy.
    Wajchenberg BL; Liberman B; Gomes EN; Pieroni RR
    Horm Metab Res; 1980 Oct; 12(10):516-9. PubMed ID: 7439876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian rhythm in plasma immunoreactive somatomedin-C in children.
    Nicolau GY; Haus E; Lakatua D; Plîngă L; Sackett-Lundeen L; Berg H; Ungureanu E; Petrescu E
    Endocrinologie; 1985; 23(2):97-103. PubMed ID: 4041074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceleration of growth in two children treated with human growth hormone-releasing factor.
    Thorner MO; Reschke J; Chitwood J; Rogol AD; Furlanetto R; Rivier J; Vale W; Blizzard RM
    N Engl J Med; 1985 Jan; 312(1):4-9. PubMed ID: 3917299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma somatomedin activity and urinary hydroxyproline excretion during administration of human growth hormone in children with short stature. Short-term effects.
    Wit JM; Van den Brande JL
    Horm Res; 1984; 19(4):205-15. PubMed ID: 6745841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth and somatomedin responses to growth hormone in Down's syndrome.
    Annerén G; Sara VR; Hall K; Tuvemo T
    Arch Dis Child; 1986 Jan; 61(1):48-52. PubMed ID: 2937371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low serum somatomedin activity in celiac disease. A misleading aspect in growth failure from asymptomatic celiac disease.
    Lecornu M; David L; François R
    Helv Paediatr Acta; 1978 Dec; 33(6):509-16. PubMed ID: 738901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatomedin, transferrin and amino-acids in serum following injection of human growth hormone in children with growth disease.
    Repellin AM; Schimpff RM; Georges P; Job JC
    Horm Metab Res; 1984 Oct; 16(10):539-43. PubMed ID: 6500489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term monitoring of treatment with recombinant human growth hormone by serial determinations of type III procollagen-related antigens in serum.
    Danne T; Grüters A; Schnabel K; Burger W; L'Allemand D; Enders I; Helge H; Weber B
    Pediatr Res; 1988 Feb; 23(2):167-71. PubMed ID: 3353159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of seasonal influence on growth hormone therapy.
    Kollipara S; Connors MH
    Growth; 1985; 49(3):341-5. PubMed ID: 4085901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH.
    Kowarski AA; Schneider J; Ben-Galim E; Weldon VV; Daughaday WH
    J Clin Endocrinol Metab; 1978 Aug; 47(2):461-4. PubMed ID: 263308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of growth and somatomedin C responses following growth hormone treatment in children with small-for-date short stature, significant idiopathic short stature and hypopituitarism.
    Grunt JA; Howard CP; Daughaday WH
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):168-74. PubMed ID: 6539552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma somatomedin activity and urinary hydroxyproline excretion during administration of human growth hormone in children with short stature. Long-term effects and relation with short-term changes.
    Wit JM; Van den Brande JL
    Horm Res; 1984; 19(4):216-23. PubMed ID: 6745842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Activity of blood somatomedin during childhood in normal subjects and in delayed growth].
    Pierson M; Grignon G; Malaprade D; Hartemann P
    Ann Biol Clin (Paris); 1976; 34(1):11-8. PubMed ID: 970694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma somatomedin activity measured as thymidine factor in normal children with average and constitutionally tall stature.
    Bozzola M; Schimpff RM; Thieriot-Prévost G; Leduc B; Job JC
    Horm Metab Res; 1982 Jul; 14(7):372-5. PubMed ID: 7118060
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of constitutional delay of growth and adolescence with human growth hormone.
    Bierich JR
    Klin Padiatr; 1983; 195(5):309-16. PubMed ID: 6632708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic growth retardation with normal growth hormone response to provocative stimuli and low somatomedin activity. Long-term therapy with human growth hormone.
    Carrascosa A; Vicens-Calvet E; Audi L; Gusinye M; Albisu M; Potau N
    Acta Paediatr Scand; 1987 May; 76(3):489-94. PubMed ID: 3604666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutritional intake, somatomedin activity and linear growth in children undergoing hemodialysis.
    Pennisi AJ; Phillips LS; Uittenbogaart C; Ettenger RB; Malekzadeh MH; Fine RN
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():181-3. PubMed ID: 1029883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Craniopharyngioma: the role of insulin in promoting postoperative growth.
    Costin G; Kogut MD; Phillips LS; Daughaday WH
    J Clin Endocrinol Metab; 1976 Feb; 42(2):370-9. PubMed ID: 1262435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seasonal variation in growth during growth hormone therapy.
    Rudolf MC; Zadik Z; Linn S; Hochberg Z
    Am J Dis Child; 1991 Jul; 145(7):769-72. PubMed ID: 2058608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.